vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
AMERICAN SUPERCONDUCTOR CORP is the larger business by last-quarter revenue ($74.5M vs $47.7M, roughly 1.6× IRONWOOD PHARMACEUTICALS INC). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs -4.8%, a 162.8% gap on every dollar of revenue. On growth, AMERICAN SUPERCONDUCTOR CORP posted the faster year-over-year revenue change (21.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $2.4M). Over the past eight quarters, AMERICAN SUPERCONDUCTOR CORP's revenue compounded faster (33.2% CAGR vs -20.2%).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
AMSC vs IRWD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $47.7M |
| Net Profit | $117.8M | $-2.3M |
| Gross Margin | 30.7% | — |
| Operating Margin | 4.5% | 14.3% |
| Net Margin | 158.1% | -4.8% |
| Revenue YoY | 21.4% | -47.3% |
| Net Profit YoY | 4679.1% | -200.9% |
| EPS (diluted) | $2.62 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $47.7M | ||
| Q3 25 | $65.9M | $122.1M | ||
| Q2 25 | $72.4M | $85.2M | ||
| Q1 25 | $66.7M | $41.1M | ||
| Q4 24 | $61.4M | $90.5M | ||
| Q3 24 | $54.5M | $91.6M | ||
| Q2 24 | $40.3M | $94.4M | ||
| Q1 24 | $42.0M | $74.9M |
| Q4 25 | $117.8M | $-2.3M | ||
| Q3 25 | $4.8M | $40.1M | ||
| Q2 25 | $6.7M | $23.6M | ||
| Q1 25 | $1.2M | $-37.4M | ||
| Q4 24 | $2.5M | $2.3M | ||
| Q3 24 | $4.9M | $3.6M | ||
| Q2 24 | $-2.5M | $-860.0K | ||
| Q1 24 | $-1.6M | $-4.2M |
| Q4 25 | 30.7% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 33.8% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 28.7% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 4.5% | 14.3% | ||
| Q3 25 | 4.5% | 61.8% | ||
| Q2 25 | 7.8% | 53.2% | ||
| Q1 25 | 2.5% | -70.7% | ||
| Q4 24 | 2.1% | 34.8% | ||
| Q3 24 | -1.4% | 28.0% | ||
| Q2 24 | -8.2% | 26.5% | ||
| Q1 24 | -5.3% | 14.7% |
| Q4 25 | 158.1% | -4.8% | ||
| Q3 25 | 7.2% | 32.8% | ||
| Q2 25 | 9.3% | 27.7% | ||
| Q1 25 | 1.8% | -90.9% | ||
| Q4 24 | 4.0% | 2.5% | ||
| Q3 24 | 9.0% | 4.0% | ||
| Q2 24 | -6.3% | -0.9% | ||
| Q1 24 | -3.8% | -5.6% |
| Q4 25 | $2.62 | $0.01 | ||
| Q3 25 | $0.11 | $0.23 | ||
| Q2 25 | $0.17 | $0.14 | ||
| Q1 25 | $0.04 | $-0.23 | ||
| Q4 24 | $0.06 | $0.03 | ||
| Q3 24 | $0.13 | $0.02 | ||
| Q2 24 | $-0.07 | $-0.01 | ||
| Q1 24 | $-0.03 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $536.8M | $-261.8M |
| Total Assets | $719.5M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $215.5M | ||
| Q3 25 | $212.9M | $140.4M | ||
| Q2 25 | $207.9M | $92.9M | ||
| Q1 25 | $79.5M | $108.5M | ||
| Q4 24 | $75.2M | $88.6M | ||
| Q3 24 | $72.1M | $88.2M | ||
| Q2 24 | $93.5M | $105.5M | ||
| Q1 24 | $90.5M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $536.8M | $-261.8M | ||
| Q3 25 | $342.2M | $-264.2M | ||
| Q2 25 | $333.1M | $-308.2M | ||
| Q1 25 | $197.1M | $-334.1M | ||
| Q4 24 | $192.7M | $-301.3M | ||
| Q3 24 | $187.0M | $-311.3M | ||
| Q2 24 | $143.3M | $-321.7M | ||
| Q1 24 | $144.6M | $-330.5M |
| Q4 25 | $719.5M | $396.9M | ||
| Q3 25 | $445.6M | $396.1M | ||
| Q2 25 | $452.8M | $342.9M | ||
| Q1 25 | $310.5M | $327.2M | ||
| Q4 24 | $310.3M | $350.9M | ||
| Q3 24 | $298.4M | $389.5M | ||
| Q2 24 | $240.1M | $395.6M | ||
| Q1 24 | $232.8M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $74.6M |
| Free Cash FlowOCF − Capex | $2.4M | $74.6M |
| FCF MarginFCF / Revenue | 3.2% | 156.3% |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $74.6M | ||
| Q3 25 | $6.5M | $47.6M | ||
| Q2 25 | $4.1M | $-15.1M | ||
| Q1 25 | $6.3M | $20.0M | ||
| Q4 24 | $5.9M | $15.2M | ||
| Q3 24 | $12.7M | $9.9M | ||
| Q2 24 | $3.4M | $33.5M | ||
| Q1 24 | $2.2M | $45.0M |
| Q4 25 | $2.4M | $74.6M | ||
| Q3 25 | $5.1M | $47.6M | ||
| Q2 25 | $3.3M | $-15.1M | ||
| Q1 25 | $5.3M | $19.9M | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $12.1M | $9.9M | ||
| Q2 24 | $3.1M | $33.4M | ||
| Q1 24 | $1.9M | $44.9M |
| Q4 25 | 3.2% | 156.3% | ||
| Q3 25 | 7.7% | 39.0% | ||
| Q2 25 | 4.6% | -17.7% | ||
| Q1 25 | 7.9% | 48.4% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 22.3% | 10.8% | ||
| Q2 24 | 7.8% | 35.4% | ||
| Q1 24 | 4.6% | 60.0% |
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.6% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 0.7% | 0.1% |
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | 1.19× | ||
| Q2 25 | 0.61× | -0.64× | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | 6.74× | ||
| Q3 24 | 2.60× | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
IRWD
Segment breakdown not available.
